Name
#199 - Sarcoidosis in the Military may be Chronic Beryllium Disease
Date & Time
Monday, February 12, 2024, 12:00 PM
Speakers
Description
Recent publications reported a higher incidence of sarcoidosis in military personnel than in the general population. Beryllium is used in multiple high tech military applications. Sarcoidosis and beryllium health effects including chronic beryllium disease (CBD) share the same symptoms as pulmonary sarcoidosis, and use of the beryllium lymphocyte proliferation test (BeLPT) to correctly identify personnel with CBD to limit further exposures. OSHA mandates the use of the BeLPT in civilian workers occupationally exposed to beryllium. Use of the test in military populations would permit current personnel and veterans to receive an accurate diagnosis and proper treatment and follow-up.
Location Name
Prince Georges Exhibit Hall A/B
Content Presented on Behalf of
Other entity not listed
Learning Outcomes
1. Identify the major pathway for beryllium exposure in an occupational setting.
2. Interpret the important factors that determine risk for beryllium health effects after exposure.
3. Summarize the current OSHA PEL and STEL for beryllium exposure.
4. Compare the clinical characteristics of sarcoidosis and chronic beryllium disease (CBD)
2. Interpret the important factors that determine risk for beryllium health effects after exposure.
3. Summarize the current OSHA PEL and STEL for beryllium exposure.
4. Compare the clinical characteristics of sarcoidosis and chronic beryllium disease (CBD)
Session Type
Posters
Dropdown Content Presented On Behalf Of:
Other entity not listed